Critical appraisal of ticagrelor in the management of acute coronary syndrome
James J Nawarskas, Stanley S SnowdenUniversity of New Mexico College of Pharmacy, Albuquerque, NM, USAAbstract: ORG CANNELLINI BEANS Ticagrelor is a novel P2Y12 receptor antagonist which, like clopidogrel and prasugrel, functions by blocking adenosine diphosphate-mediated platelet aggregation.However, unlike the aforementioned agents, the binding o